Global mAb Biosimilar Sales Market Report 2016

October 2016 | 115 pages | ID: GEF27322E8EEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of mAb Biosimilar

Revenue, means the sales value of mAb Biosimilar

This report studies sales (consumption) of mAb Biosimilar in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Baxter
• GSK
• Merck
• Novartis
• Pfizer
• Roche Holding
• Sanofi
• Mitsubishi Tanabe Pharma
• Hospira
• Alvartis Pharma
• Allergan
• Amega Biotech
• Biogen
• LG Lifesciences
• Samsung Biologics

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of mAb Biosimilar in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of mAb Biosimilar in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global mAb Biosimilar Sales Market Report 2016

1 MAB BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of mAb Biosimilar
1.2 Classification of mAb Biosimilar
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of mAb Biosimilar
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 mAb Biosimilar Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of mAb Biosimilar (2011-2021)
  1.5.1 Global mAb Biosimilar Sales and Growth Rate (2011-2021)
  1.5.2 Global mAb Biosimilar Revenue and Growth Rate (2011-2021)

2 GLOBAL MAB BIOSIMILAR COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global mAb Biosimilar Market Competition by Manufacturers
  2.1.1 Global mAb Biosimilar Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global mAb Biosimilar Revenue and Share by Manufacturers (2011-2016)
2.2 Global mAb Biosimilar (Volume and Value) by Type
  2.2.1 Global mAb Biosimilar Sales and Market Share by Type (2011-2016)
  2.2.2 Global mAb Biosimilar Revenue and Market Share by Type (2011-2016)
2.3 Global mAb Biosimilar (Volume and Value) by Regions
  2.3.1 Global mAb Biosimilar Sales and Market Share by Regions (2011-2016)
  2.3.2 Global mAb Biosimilar Revenue and Market Share by Regions (2011-2016)
2.4 Global mAb Biosimilar (Volume) by Application

3 UNITED STATES MAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

3.1 United States mAb Biosimilar Sales and Value (2011-2016)
  3.1.1 United States mAb Biosimilar Sales and Growth Rate (2011-2016)
  3.1.2 United States mAb Biosimilar Revenue and Growth Rate (2011-2016)
  3.1.3 United States mAb Biosimilar Sales Price Trend (2011-2016)
3.2 United States mAb Biosimilar Sales and Market Share by Manufacturers
3.3 United States mAb Biosimilar Sales and Market Share by Type
3.4 United States mAb Biosimilar Sales and Market Share by Application

4 CHINA MAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

4.1 China mAb Biosimilar Sales and Value (2011-2016)
  4.1.1 China mAb Biosimilar Sales and Growth Rate (2011-2016)
  4.1.2 China mAb Biosimilar Revenue and Growth Rate (2011-2016)
  4.1.3 China mAb Biosimilar Sales Price Trend (2011-2016)
4.2 China mAb Biosimilar Sales and Market Share by Manufacturers
4.3 China mAb Biosimilar Sales and Market Share by Type
4.4 China mAb Biosimilar Sales and Market Share by Application

5 EUROPE MAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

5.1 Europe mAb Biosimilar Sales and Value (2011-2016)
  5.1.1 Europe mAb Biosimilar Sales and Growth Rate (2011-2016)
  5.1.2 Europe mAb Biosimilar Revenue and Growth Rate (2011-2016)
  5.1.3 Europe mAb Biosimilar Sales Price Trend (2011-2016)
5.2 Europe mAb Biosimilar Sales and Market Share by Manufacturers
5.3 Europe mAb Biosimilar Sales and Market Share by Type
5.4 Europe mAb Biosimilar Sales and Market Share by Application

6 JAPAN MAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

6.1 Japan mAb Biosimilar Sales and Value (2011-2016)
  6.1.1 Japan mAb Biosimilar Sales and Growth Rate (2011-2016)
  6.1.2 Japan mAb Biosimilar Revenue and Growth Rate (2011-2016)
  6.1.3 Japan mAb Biosimilar Sales Price Trend (2011-2016)
6.2 Japan mAb Biosimilar Sales and Market Share by Manufacturers
6.3 Japan mAb Biosimilar Sales and Market Share by Type
6.4 Japan mAb Biosimilar Sales and Market Share by Application

7 GLOBAL MAB BIOSIMILAR MANUFACTURERS ANALYSIS

7.1 Baxter
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 mAb Biosimilar Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Baxter mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 GSK
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 115 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 GSK mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Merck
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 132 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Merck mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Novartis
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Oct Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Novartis mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Roche Holding
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Roche Holding mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Sanofi
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Sanofi mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Mitsubishi Tanabe Pharma
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Mitsubishi Tanabe Pharma mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Hospira
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Hospira mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Alvartis Pharma
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Alvartis Pharma mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Allergan
7.12 Amega Biotech
7.13 Biogen
7.14 LG Lifesciences
7.15 Samsung Biologics

8 MAB BIOSIMILAR MAUFACTURING COST ANALYSIS

8.1 mAb Biosimilar Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of mAb Biosimilar

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 mAb Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of mAb Biosimilar Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL MAB BIOSIMILAR MARKET FORECAST (2016-2021)

12.1 Global mAb Biosimilar Sales, Revenue Forecast (2016-2021)
12.2 Global mAb Biosimilar Sales Forecast by Regions (2016-2021)
12.3 Global mAb Biosimilar Sales Forecast by Type (2016-2021)
12.4 Global mAb Biosimilar Sales Forecast by Application (2016-2021)

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of mAb Biosimilar
Table Classification of mAb Biosimilar
Figure Global Sales Market Share of mAb Biosimilar by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of mAb Biosimilar
Figure Global Sales Market Share of mAb Biosimilar by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States mAb Biosimilar Revenue and Growth Rate (2011-2021)
Figure China mAb Biosimilar Revenue and Growth Rate (2011-2021)
Figure Europe mAb Biosimilar Revenue and Growth Rate (2011-2021)
Figure Japan mAb Biosimilar Revenue and Growth Rate (2011-2021)
Figure Global mAb Biosimilar Sales and Growth Rate (2011-2021)
Figure Global mAb Biosimilar Revenue and Growth Rate (2011-2021)
Table Global mAb Biosimilar Sales of Key Manufacturers (2011-2016)
Table Global mAb Biosimilar Sales Share by Manufacturers (2011-2016)
Figure 2015 mAb Biosimilar Sales Share by Manufacturers
Figure 2016 mAb Biosimilar Sales Share by Manufacturers
Table Global mAb Biosimilar Revenue by Manufacturers (2011-2016)
Table Global mAb Biosimilar Revenue Share by Manufacturers (2011-2016)
Table 2015 Global mAb Biosimilar Revenue Share by Manufacturers
Table 2016 Global mAb Biosimilar Revenue Share by Manufacturers
Table Global mAb Biosimilar Sales and Market Share by Type (2011-2016)
Table Global mAb Biosimilar Sales Share by Type (2011-2016)
Figure Sales Market Share of mAb Biosimilar by Type (2011-2016)
Figure Global mAb Biosimilar Sales Growth Rate by Type (2011-2016)
Table Global mAb Biosimilar Revenue and Market Share by Type (2011-2016)
Table Global mAb Biosimilar Revenue Share by Type (2011-2016)
Figure Revenue Market Share of mAb Biosimilar by Type (2011-2016)
Figure Global mAb Biosimilar Revenue Growth Rate by Type (2011-2016)
Table Global mAb Biosimilar Sales and Market Share by Regions (2011-2016)
Table Global mAb Biosimilar Sales Share by Regions (2011-2016)
Figure Sales Market Share of mAb Biosimilar by Regions (2011-2016)
Figure Global mAb Biosimilar Sales Growth Rate by Regions (2011-2016)
Table Global mAb Biosimilar Revenue and Market Share by Regions (2011-2016)
Table Global mAb Biosimilar Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of mAb Biosimilar by Regions (2011-2016)
Figure Global mAb Biosimilar Revenue Growth Rate by Regions (2011-2016)
Table Global mAb Biosimilar Sales and Market Share by Application (2011-2016)
Table Global mAb Biosimilar Sales Share by Application (2011-2016)
Figure Sales Market Share of mAb Biosimilar by Application (2011-2016)
Figure Global mAb Biosimilar Sales Growth Rate by Application (2011-2016)
Figure United States mAb Biosimilar Sales and Growth Rate (2011-2016)
Figure United States mAb Biosimilar Revenue and Growth Rate (2011-2016)
Figure United States mAb Biosimilar Sales Price Trend (2011-2016)
Table United States mAb Biosimilar Sales by Manufacturers (2011-2016)
Table United States mAb Biosimilar Market Share by Manufacturers (2011-2016)
Table United States mAb Biosimilar Sales by Type (2011-2016)
Table United States mAb Biosimilar Market Share by Type (2011-2016)
Table United States mAb Biosimilar Sales by Application (2011-2016)
Table United States mAb Biosimilar Market Share by Application (2011-2016)
Figure China mAb Biosimilar Sales and Growth Rate (2011-2016)
Figure China mAb Biosimilar Revenue and Growth Rate (2011-2016)
Figure China mAb Biosimilar Sales Price Trend (2011-2016)
Table China mAb Biosimilar Sales by Manufacturers (2011-2016)
Table China mAb Biosimilar Market Share by Manufacturers (2011-2016)
Table China mAb Biosimilar Sales by Type (2011-2016)
Table China mAb Biosimilar Market Share by Type (2011-2016)
Table China mAb Biosimilar Sales by Application (2011-2016)
Table China mAb Biosimilar Market Share by Application (2011-2016)
Figure Europe mAb Biosimilar Sales and Growth Rate (2011-2016)
Figure Europe mAb Biosimilar Revenue and Growth Rate (2011-2016)
Figure Europe mAb Biosimilar Sales Price Trend (2011-2016)
Table Europe mAb Biosimilar Sales by Manufacturers (2011-2016)
Table Europe mAb Biosimilar Market Share by Manufacturers (2011-2016)
Table Europe mAb Biosimilar Sales by Type (2011-2016)
Table Europe mAb Biosimilar Market Share by Type (2011-2016)
Table Europe mAb Biosimilar Sales by Application (2011-2016)
Table Europe mAb Biosimilar Market Share by Application (2011-2016)
Figure Japan mAb Biosimilar Sales and Growth Rate (2011-2016)
Figure Japan mAb Biosimilar Revenue and Growth Rate (2011-2016)
Figure Japan mAb Biosimilar Sales Price Trend (2011-2016)
Table Japan mAb Biosimilar Sales by Manufacturers (2011-2016)
Table Japan mAb Biosimilar Market Share by Manufacturers (2011-2016)
Table Japan mAb Biosimilar Sales by Type (2011-2016)
Table Japan mAb Biosimilar Market Share by Type (2011-2016)
Table Japan mAb Biosimilar Sales by Application (2011-2016)
Table Japan mAb Biosimilar Market Share by Application (2011-2016)
Table Baxter Basic Information List
Table Baxter mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter mAb Biosimilar Global Market Share (2011-2016)
Table GSK Basic Information List
Table GSK mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK mAb Biosimilar Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck mAb Biosimilar Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis mAb Biosimilar Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer mAb Biosimilar Global Market Share (2011-2016)
Table Roche Holding Basic Information List
Table Roche Holding mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Holding mAb Biosimilar Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi mAb Biosimilar Global Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Basic Information List
Table Mitsubishi Tanabe Pharma mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mitsubishi Tanabe Pharma mAb Biosimilar Global Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira mAb Biosimilar Global Market Share (2011-2016)
Table Alvartis Pharma Basic Information List
Table Alvartis Pharma mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alvartis Pharma mAb Biosimilar Global Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan mAb Biosimilar Global Market Share (2011-2016)
Table Amega Biotech Basic Information List
Table Amega Biotech mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amega Biotech mAb Biosimilar Global Market Share (2011-2016)
Table Biogen Basic Information List
Table Biogen mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen mAb Biosimilar Global Market Share (2011-2016)
Table LG Lifesciences Basic Information List
Table LG Lifesciences mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure LG Lifesciences mAb Biosimilar Global Market Share (2011-2016)
Table Samsung Biologics Basic Information List
Table Samsung Biologics mAb Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Samsung Biologics mAb Biosimilar Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of mAb Biosimilar
Figure Manufacturing Process Analysis of mAb Biosimilar
Figure mAb Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of mAb Biosimilar Major Manufacturers in 2015
Table Major Buyers of mAb Biosimilar
Table Distributors/Traders List
Figure Global mAb Biosimilar Sales and Growth Rate Forecast (2016-2021)
Figure Global mAb Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Table Global mAb Biosimilar Sales Forecast by Regions (2016-2021)
Table Global mAb Biosimilar Sales Forecast by Type (2016-2021)
Table Global mAb Biosimilar Sales Forecast by Application (2016-2021)